We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $248M invested in Rigel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $115K | Put options by funds: $35K

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

26% more capital invested

Capital invested by funds: $197M → $248M (+$50.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 122 → 121 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
49
Reduced
31
Closed
10
Calls
$115K
Puts
$35K
Net Calls
+$80K
Net Calls Change
+$61K

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
+$3.34M
2
BFA
BlackRock Fund Advisors
California
+$3.33M
3
PC
Paulson & Co
New York
+$1.6M
4
Millennium Management
Millennium Management
New York
+$1.12M
5
ACP
Acuta Capital Partners
California
+$776K

Top Sellers

1
BC
Broadfin Capital
New York
-$6.06M
2
TC
TFS Capital
Pennsylvania
-$843K
3
UBS AM
UBS AM
Illinois
-$634K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$619K
5
MOACM
Mutual of America Capital Management
New York
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
101
BNP Paribas Financial Markets
France
$51.2K -$5.67K -187 -10%
Balyasny Asset Management
102
Balyasny Asset Management
Illinois
$46K +$46.4K +1,532 New
FANJ
103
Financial Architects (New Jersey)
New Jersey
$45K – – –
Principal Financial Group
104
Principal Financial Group
Iowa
$45K – – –
Creative Planning
105
Creative Planning
Kansas
$42K +$12.1K +400 +40%
SCM
106
Stevens Capital Management
Pennsylvania
$39K -$6.64K -219 -15%
Walleye Trading
107
Walleye Trading
New York
$36K -$25.5K -840 -41%
EEG
108
E.E. Geduld
$30K -$15.2K -500 -33%
HighTower Advisors
109
HighTower Advisors
Illinois
$30K – – –
BJ
110
BlackRock Japan
Japan
$15K -$6.03K -199 -28%
MA
111
MUFG Americas
New York
$10K +$10.2K +337 New
BlackRock
112
BlackRock
New York
$6K – – –
Barclays
113
Barclays
United Kingdom
$6K +$2.09K +69 +56%
CAW
114
Cornerstone Advisors (Washington)
Washington
$4K – – –
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
$3K -$12K -395 -81%
WA
116
WealthTrust-Arizona
Arizona
$3K – – –
PNC Financial Services Group
117
PNC Financial Services Group
Pennsylvania
$2K -$18.2K -600 -89%
UMA
118
USA Mutuals Advisors
Texas
$2K +$2.37K +78 New
Manulife (Manufacturers Life Insurance)
119
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$188 +$6.79K +224 +4%
MOACM
120
Mutual of America Capital Management
New York
– -$422K -17,080 Closed
OAM
121
Oxford Asset Management
United Kingdom
– -$259K -10,480 Closed
CSS
122
Cubist Systematic Strategies
Connecticut
– -$44K -1,801 Closed
NCCM
123
Nine Chapters Capital Management
New Jersey
– -$42K -1,700 Closed
DTL
124
Dynamic Technology Lab
Singapore
– -$39K -1,567 Closed
VAM
125
Visium Asset Management
New York
– -$30K -1,200 Closed
2 3 4
5
6

RIGL Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2015, worth a combined $248M — up 26% from $197M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 49 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $3.34M. The largest seller was Broadfin Capital, cutting an estimated $6.06M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2015, down from 122 in Q3 2015.
  • Funds reported $248M of Rigel Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q4 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q4 2015 was Rock Springs Capital Management, an estimated $3.34M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2015 was Broadfin Capital, an estimated $6.06M sold.

Based on aggregated 13F filings for Q4 2015.